aripiprazole has been researched along with sertraline in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 16 (59.26) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Jung, ME; Kang, SY; Kim, HJ; Kim, J; Kim, MJ; Kim, MS; Lee, J; Lee, KN; Lee, M; Lee, SH; Park, EJ; Park, WK; Seo, HJ; Son, EJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cohen, ST; Pies, R; Rulf, D | 1 |
| Pinninti, NR; Sanghadia, M | 1 |
| Geffken, GR; Lehmkuhl, H; Murphy, TK; Storch, EA; Touchton, A | 1 |
| Burrows, G; Jefferys, D | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Bellino, S; Bogetto, F; Paradiso, E | 1 |
| Terao, T | 1 |
| Gambini, O; Muffatti, R; Scarone, S | 1 |
| Callen, EC; Church, CO | 1 |
| Jang, FL; Lin, CH; Lin, SH | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Hori, H; Ikenouchi-Sugita, A; Iwata, N; Katsuki, A; Kishi, T; Nakamura, J; Umene-Nakano, W; Yoshimura, R | 1 |
| Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Alpert, JE; Baer, L; Clain, AJ; Cusin, C; Fava, M; Hylek, L; Ionescu, DF; Mischoulon, D; Soskin, DP; Yeung, AS | 1 |
| Hasegawa, S; Hida, H; Miyake, Y; Mouri, A; Nabeshima, T; Noda, Y; Ozaki, N; Yamada, K; Yoshimi, A | 1 |
| Kobayashi, N; Takano, M | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Kamijima, K; Kimura, M; Kitayama, Y; Kuwahara, K; Tadori, Y | 1 |
| Bian, Y; Ma, B; Wang, Z; Yang, F | 1 |
| Arakawa, H; Ishii, M; Ito, MA; Mizoi, K; Morishita, H; Ogihara, T; Okawa, K; Yano, K | 1 |
| Ito, MA; Mizoi, K; Morishita, H; Ogihara, T; Perera, LMB; Yano, K; Zhang, X | 1 |
2 review(s) available for aripiprazole and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
6 trial(s) available for aripiprazole and sertraline
| Article | Year |
|---|---|
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Treatment Outcome; Young Adult | 2011 |
Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline | 2012 |
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.
Topics: Adult; Antidepressive Agents; Aripiprazole; Central Nervous System Stimulants; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Sertraline; Treatment Outcome | 2017 |
Randomized, double-blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasopharyngitis; Outcome Assessment, Health Care; Sertraline; Single-Blind Method; Young Adult | 2018 |
19 other study(ies) available for aripiprazole and sertraline
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
Topics: Animals; Antidepressive Agents; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Mice; Motor Activity; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2011 |
Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Aripiprazole-associated acute dystonia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Drug Interactions; Dystonia; Female; Humans; Piperazines; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sertraline | 2008 |
Reversal of trichotillomania with aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Morpholines; Piperazines; Quinolones; Reboxetine; Self Concept; Sertraline; Social Adjustment; Trichotillomania | 2008 |
Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Anxiety; Aripiprazole; Borderline Personality Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Drug Therapy, Combination; Headache; Humans; Middle Aged; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2008 |
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis | 2008 |
An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Delusions; Electroencephalography; Female; Hallucinations; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Olfactory Bulb; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Smell | 2008 |
Myxedema coma associated with combination aripiprazole and sertraline therapy.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Coma; Drug Interactions; Humans; Male; Myxedema; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid | 2013 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Dysfunction of Serotonergic and Dopaminergic Neuronal Systems in the Antidepressant-Resistant Impairment of Social Behaviors Induced by Social Defeat Stress Exposure as Juveniles.
Topics: Animals; Antidepressive Agents; Aripiprazole; Brain; Depressive Disorder, Treatment-Resistant; Desipramine; Disease Models, Animal; Dominance-Subordination; Dopamine; Drug Therapy, Combination; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Norepinephrine; Serotonin; Sertraline; Sexual Maturation; Social Behavior; Stress, Psychological | 2018 |
Aripiprazole-induced sleep-related eating disorder: a case report.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depression; Drug Therapy, Combination; Humans; Male; Night Eating Syndrome; Sertraline; Sleep Wake Disorders | 2018 |
People allergic to me and body dysmorphic disorder.
Topics: Adolescent; Aripiprazole; Body Dysmorphic Disorders; Cognitive Behavioral Therapy; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Interpersonal Relations; Neurotransmitter Agents; Sertraline; Social Isolation; Treatment Outcome | 2019 |
Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Drug Interactions; Gastrointestinal Absorption; Humans; LLC-PK1 Cells; Pimozide; Sertraline; Swine | 2020 |
P-Glycoprotein-Mediated Pharmacokinetic Interactions Increase Pimozide hERG Channel Inhibition.
Topics: Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Humans; Male; Pimozide; Potassium Channel Blockers; Sertraline | 2022 |